Rockeby biomed launches rapid diagnostic kit for HIV in Singapore
Rockeby biomed has reached an agreement with OraSure Technologies to serve as the exclusive distributor in Singapore of the OraQuick™ Rapid HIV 1/2 Antibody Test.
The announcement was made in conjunction with World AIDS Day, a global effort that is commemorated annually on December 1. Rockeby will immediately launch a pilot program and, pursuant to the agreement, intends to distribute and market OraQuick™ to governmental agencies, hospitals, licensed physicians, clinics, and outreach and rehabilitation centers throughout Singapore.
The OraQuick™ test can detect the presence of antibodies to both HIV-1 and HIV-2 and is suitable for use with oral fluid, venipuncture and fingerstick whole blood samples. The results of the test are available within 20 minutes. The test kit is easy to use and with oral fluid, requires no needles or hazardous waste disposal and has an accuracy greater than 99 percent. A similar rapid HIV test sold by OraSure in the United States has received approval by the US Food and Drug Administration.
“This technology will markedly increase access to HIV testing, which is of great importance as the global epidemic increases. The availability of an accurate test will increase the number of people who can be put on the appropriate medication earlier, thus delaying the onset of AIDS,” said Dr Sze Wee Tan, Managing Director and Chief Executive of Rockeby.
RBY Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
